DCW Limited has informed the Exchange about Investor Presentation
DCW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
DCW Limited shared its Q4-FY25 and FY25 investor presentation. FY25 revenue grew 6.9% YoY to INR 20,003 Mn, driven by a 43% jump in Specialty Chemicals revenue to INR 5,257 Mn. Annual EBITDA rose 10.2% YoY to INR 1,934 Mn with margins improving 29 bps to 9.67%, while PAT nearly doubled to INR 303 Mn (EPS INR 1.03, up 94.3%). Q4 was weak though — revenue fell 13.5% YoY to INR 5,379 Mn and PAT declined 25.5% YoY due to weak export demand and lower realizations in Synthetic Rutile and Soda Ash. The company completed its 44.5 MW renewable power project in April 2025 and is expanding CPVC capacity from 21,600 TPA to 50,000 TPA, reportedly ahead of schedule. Net Debt/EBITDA improved to 1.09x with term borrowings reduced by INR 440 Mn.
Mixed signals for the stock — strong full-year performance and margin expansion led by Specialty Chemicals are positives, but Q4 softness in Basic Chemicals highlights near-term pricing headwinds. Debt reduction and ahead-of-schedule capex execution support the long-term growth story.